The Ketone Conversation: Removing Barriers and Rethinking Monitoring
Released On
July 28, 2025
Expires On
July 28, 2026
Media Type
Internet
Completion Time
15 minutes
Specialty
Diabetology, Endocrinology, Primary Care
Topics
Diabetes, Diabetic Ketoacidosis
Other modules in the Ketone Masterclass series
- Access: The DKA playbook: Applying Guidelines to Real-World Diagnosis
- Access: Pathways to Prevention: Understanding the Mechanisms Driving DKA
- Access: Beyond the Strip: Innovations in Ketone Monitoring and Clinical Applications
Acknowledgement
This activity is supported by an independent educational grant from Abbott
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of US-based primary care physicians (PCPs) who are looking to improve their knowledge and skills in ketone monitoring technology for patients with T2D.
Program Overview
Welcome to this Ketone Masterclass Module, which is a part of the larger CME-accredited program, Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management.
Developed by Dr. David Kerr, MBChB, DM, FRCP, FRCPE, this masterclass uncovers challenges to ketone monitoring and explores strategies to overcome these barriers, including empowering patients to use ketone monitoring effectively.
*Ready-to-use in the clinic: download the quick reference practice aid, summarizing this masterclass
---
This activity is part of the larger CME-accredited program Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management. Register for free to continue your Ketone Monitoring Masterclass journey or tune into conference highlights with program Director Dr. David Kerr. MBChB, DM, FRCP, FRCPE. © 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify patient barriers preventing optimal ketone monitoring
Faculty
David Kerr, MBChB, DM, FRCP, FRCPE
Center for Health Systems Research
Sutter Health
Santa Barbara, CA, USA
Dr David Kerr, MBChB, DM, FRCP, FRCPE, a UK-trained endocrinologist, is currently Senior Investigator in Diabetes and Digital Health Equity at the Sutter Health Center for Health Systems Research in Santa Barbara, California (https://www.davidkerrmd.com/).
Dr Kerr’s recent research has focused on offering wearable digital health technologies, such as CGM devices, to marginalized and historically excluded communities to help them understand the potential value of real-time physiologic data. He has published more than 400 articles, commentaries, and opinion pieces, as well as co-authored the first three books focusing on diabetes and digital health. Dr Kerr has a Google Scholar i10-index of 173 and an h-index of 54.
Dr Kerr’s research has also included the use of “food as medicine” for adults with or at risk of diabetes. He has published the outcomes showing measurable clinical and mental health benefits from the prescription of fresh vegetable produce. Dr Kerr also has an adjunct position in the Department of Computer Science and Electrical Engineering at Rice University in Houston, Texas, is a member of the research committee of the Association of Diabetes Care and Education Specialists, and was recently co-chair of an NIDDK working group that looked at the impact of innovation on furthering research into the heterogeneity of diabetes.
You can follow Dr Kerr on “X” at @godiabetesmd.
Joint Accreditation Statement
In support of improving patient care, this program has been planned and implemented by the Postgraduate Institute for Medicine and Springer Health+ IME. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosure of Conflicts of Interest
Dr. David Kerr:
- Grant/research support: Abbott Diabetes Care
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Complete the pre-test.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
Faculty participating in any CME activity are required to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes for healthcare professionals only. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]